bevacizumab,atezolizumab
roche
['imbrave050', 'hcc', 'atezo', 'arca, (-arcade)']
just out #aacr23 day 3
tweet #imbrave050 results #aacr23: #atezobev (x12m) improves rfs (hr 0.72 (95%ci 0.56-0.92) in high-risk #resected #hcc best, 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨